References
1. Lehrnbecher T, Robinson P, Fisher B, et al. Guideline for
the Management of Fever and Neutropenia in Children With Cancer and
Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin
Oncol. 2017;35(18):2082-2094.
2. Kara SS, Tezer H, Polat M, et al. Risk factors for
bacteremia in children with febrile neutropenia. Turk J Med Sci.
2019;49(4):1198-1205.
3. Koçak U, Rolston KV, Mullen CA. Fever and neutropenia in
children with solid tumors is similar in severity and outcome to that in
children with leukemia. Support Care Cancer. 2002;10(1):58-64.
4. Gustinetti G, Mikulska M. Bloodstream infections in
neutropenic cancer patients: A practical update. Virulence.
2016;7(3):280-297.
5. Rackoff WR, Gonin R, Robinson C, Kreissman SG, Breitfeld PB.
Predicting the risk of bacteremia in childen with fever and neutropenia.
J Clin Oncol. 1996;14(3):919-924.
6. Ammann RA, Hirt A, Lüthy AR, Aebi C. Identification of
children presenting with fever in chemotherapy-induced neutropenia at
low risk for severe bacterial infection. Med Pediatr Oncol.
2003;41(5):436-443.
7. Ammann RA, Bodmer N, Hirt A, et al. Predicting adverse
events in children with fever and chemotherapy-induced neutropenia: the
prospective multicenter SPOG 2003 FN study. J Clin Oncol.
2010;28(12):2008-2014.
8. Alexander SW, Wade KC, Hibberd PL, Parsons SK. Evaluation of
risk prediction criteria for episodes of febrile neutropenia in children
with cancer. J Pediatr Hematol Oncol. 2002;24(1):38-42.
9. Rondinelli PI, Ribeiro KeC, de Camargo B. A proposed score
for predicting severe infection complications in children with
chemotherapy-induced febrile neutropenia. J Pediatr Hematol Oncol.
2006;28(10):665-670.
10. Santolaya ME, Alvarez AM, Avilés CL, et al. Prospective
evaluation of a model of prediction of invasive bacterial infection risk
among children with cancer, fever, and neutropenia. Clin Infect Dis.
2002;35(6):678-683.
11. Baorto EP, Aquino VM, Mullen CA, Buchanan GR, DeBaun MR.
Clinical parameters associated with low bacteremia risk in 1100
pediatric oncology patients with fever and neutropenia. Cancer.
2001;92(4):909-913.
12. Weinkove R, Clay J, Wood C. Temperature management in
haematology patients with febrile neutropenia: a practice survey. N Z
Med J. 2013;126(1373):62-73.
13. Weinkove R, Bowden E, Wood C, et al. A randomized
controlled feasibility trial of paracetamol during febrile neutropenia
in hemato-oncology patients. Leuk Lymphoma. 2019;60(6):1540-1547.
14. Dokko D. Best practice for fever management with
intravenous acetaminophen in pediatric oncology. J Pediatr Oncol Nurs.
2015;32(2):120-125.
15. Hakim H, Flynn PM, Srivastava DK, et al. Risk prediction in
pediatric cancer patients with fever and neutropenia. Pediatr Infect Dis
J. 2010;29(1):53-59.
16. Alali M, Mayampurath A, Dai Y, Bartlett AH. A prediction
model for bacteremia and transfer to intensive care in pediatric and
adolescent cancer patients with febrile neutropenia. Sci Rep.
2022;12(1):7429.
17. Ammann RA, Hirt A, Lüthy AR, Aebi C. Predicting bacteremia
in children with fever and chemotherapy-induced neutropenia. Pediatr
Infect Dis J. 2004;23(1):61-67.
18. Phillips RS, Sung L, Ammann RA, et al. Predicting
microbiologically defined infection in febrile neutropenic episodes in
children: global individual participant data multivariable
meta-analysis. Br J Cancer. 2016;114(12):e17.
19. Janssens KP, Valete COS, Silva ARAD, Ferman SE. Evaluation
of risk stratification strategies in pediatric patients with febrile
neutropenia. J Pediatr (Rio J). 2021;97(3):302-308.
20. Haeusler GM, Thursky KA, Slavin MA, et al. Risk
stratification in children with cancer and febrile neutropenia: A
national, prospective, multicentre validation of nine clinical decision
rules. EClinicalMedicine. 2020;18:100220.
21. Ojha RP, Asdahl PH, Steyerberg EW, Schroeder H. Predicting
bacterial infections among pediatric cancer patients with febrile
neutropenia: External validation of the PICNICC model. Pediatr Blood
Cancer. 2018;65(4).
22. Haeusler GM, Phillips R, Slavin MA, et al. Re-evaluating
and recalibrating predictors of bacterial infection in children with
cancer and febrile neutropenia. EClinicalMedicine. 2020;23:100394.
23. Das A, Trehan A, Oberoi S, Bansal D. Validation of risk
stratification for children with febrile neutropenia in a pediatric
oncology unit in India. Pediatr Blood Cancer. 2017;64(6).
24. Miedema KG, Tissing WJ, Abbink FC, et al. Risk-adapted
approach for fever and neutropenia in paediatric cancer patients–a
national multicentre study. Eur J Cancer. 2016;53:16-24.
25. Phillips B. Prospective cohort study of the predictive
value of inflammatory biomarkers over clinical variables in children and
young people with cancer presenting with fever and neutropenia.
F1000Res. 2021;10:1070.
26. Klaassen RJ, Goodman TR, Pham B, Doyle JJ. ”Low-risk”
prediction rule for pediatric oncology patients presenting with fever
and neutropenia. J Clin Oncol. 2000;18(5):1012-1019.